Last reviewed · How we verify
NCT06184074
Effect of Aromatase Inhibitors on Ultrasonographic Measurements and Static and Dynamic Balance Scores in Breast Cancer
trial in Breast Cancer in 76 participants. Completed in 1 August 2024.
1 May 2024
Quick facts
| Lead sponsor | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 76 |
| Start date | 1 February 2024 |
| Primary completion | 1 May 2024 |
| Estimated completion | 1 August 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
- Aromatase Inhibitors — all drugs for Aromatase Inhibitors →
- Balanced — all drugs for Balanced →
Sponsor
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Who can join
Adults 40 to 70, female only, with Breast Cancer or Aromatase Inhibitors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the effects of aromatase inhibitors on lower extremity ultrasonographic measurements, static and dynamic balance scores in breast cancer patients using aromatase inhibitors
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06184074
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey trials
Trials by the same sponsor.
- NCT07467681 — Perioperative Hypothermia and Sevoflurane Consumption in Elderly Patients · not yet recruiting
- NCT07456748 — Investigation of the Association Between Upper Crossed Syndrome and Temporomandibular Joint Dysfunction in University St · completed
- NCT07128979 — Efficacy and Safety Evaluation of Ruscus Aculeatus L in Patients With Hemorrhoids · Phase 4 · recruiting
- NCT07170449 — Investigation of the Relationship Between Ultrasonographic Parameters and Tactile Sensation in Carpal Tunnel Syndrome · recruiting
- NCT07114913 — Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06184074 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
- Last refreshed: 12 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06184074.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing